166 related articles for article (PubMed ID: 4327577)
1. Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy.
Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Ahmann P; Jordan A; Mosteller RC
J Clin Invest; 1971 Sep; 50(9):1941-9. PubMed ID: 4327577
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
Rudman D; Patterson JH; Gibbas DL
J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.
Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
J Clin Invest; 1972 May; 51(5):1118-24. PubMed ID: 5057128
[TBL] [Abstract][Full Text] [Related]
4. Diurnal variation in the responsiveness of human subjects to human growth hormone.
Rudman D; Friedes D; Patterson JH; Gibbas DL
J Clin Invest; 1973 Apr; 52(4):912-8. PubMed ID: 4693655
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy in men: hyperresponsiveness to human growth hormone.
Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne IF; Barlow JA; Ahmann P; Jordan A; Mosteller RC
Arch Phys Med Rehabil; 1972 Oct; 53(10):470-5 passim. PubMed ID: 5079860
[No Abstract] [Full Text] [Related]
6. Metabolic effects of human growth hormone in corticosteroid-treated children.
Morris HG; Jorgensen JR; Elrick H; Goldsmith RE
J Clin Invest; 1968 Mar; 47(3):436-51. PubMed ID: 5637134
[TBL] [Abstract][Full Text] [Related]
7. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
Rudman D; Kutner MH; Chawla RK; Goldsmith MA
J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
[TBL] [Abstract][Full Text] [Related]
8. Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man.
Heymsfield SB; Bethel RA; Hall EC; Mills JB; Moseley MH; Kostyo JL; Rudman D
J Clin Invest; 1977 Sep; 60(3):563-70. PubMed ID: 142777
[TBL] [Abstract][Full Text] [Related]
9. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.
Lippe BM; Van Herle AJ; LaFranchi SH; Uller RP; Lavin N; Kaplan SA
J Clin Endocrinol Metab; 1975 Apr; 40(4):612-8. PubMed ID: 165211
[TBL] [Abstract][Full Text] [Related]
10. Human growth hormone in myopathy: myotonic dystrophy, duchenne muscular dystrophy, and limb-girdle muscular dystrophy.
Chyatte SB; Rudman D; Patterson JH; Ahmann P; Jordan A
South Med J; 1974 Feb; 67(2):170-2. PubMed ID: 4811728
[No Abstract] [Full Text] [Related]
11. Comparative potency of subtilisin-cleaved and intact human growth hormone measured in growth hormone-deficient human subjects.
Bunner DL; Lewis UJ; Vanderlaan WP
J Clin Endocrinol Metab; 1979 Feb; 48(2):293-6. PubMed ID: 429482
[TBL] [Abstract][Full Text] [Related]
12. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
[TBL] [Abstract][Full Text] [Related]
13. LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: lack of effect of replacement therapy with human growth hormone.
Kelch RP; Markovs M; Huss J
J Clin Endocrinol Metab; 1976 Jun; 42(6):1104-13. PubMed ID: 777020
[TBL] [Abstract][Full Text] [Related]
14. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects.
Ho KY; Weissberger AJ; Stuart MC; Day RO; Lazarus L
Clin Endocrinol (Oxf); 1989 Apr; 30(4):335-45. PubMed ID: 2598470
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
Hedin L; Olsson B; Diczfalusy M; Flyg C; Petersson AS; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1993 Apr; 76(4):962-7. PubMed ID: 8473411
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and endogenously secreted human growth hormone on the regulation of gonadotropin secretion in female and male transgenic mice expressing the human growth hormone gene.
Chandrashekar V; Bartke A
Endocrinology; 1993 Apr; 132(4):1482-8. PubMed ID: 8462447
[TBL] [Abstract][Full Text] [Related]
19. Hyper-responsiveness of patients with limb-girdle dystrophy to human growth hormone.
Rudman D; Chyatte SB; Gerron GG; O'Beirne I; Barlow J
J Clin Endocrinol Metab; 1972 Aug; 35(2):256-60. PubMed ID: 5072356
[No Abstract] [Full Text] [Related]
20. Effect of recombinant human growth hormone on urinary 15N-nitrogen balance in girls with Turner syndrome as compared to children with growth hormone deficiency.
Rother K; Zachmann M; Kempken B; Grüters A; Schnabel D; L'Allemand D; Häusler G; Frisch H
Horm Res; 1989; 32(5-6):166-9. PubMed ID: 2634609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
